Clinical values of multimodal preventive analgesia in patients with partial hepatectomy for liver cancer
10.3760/cma.j.issn.0529-5815.2017.02.013
- VernacularTitle: 多模式预防性镇痛在肝癌肝部分切除患者围手术期的应用
- Author:
Hong ZHOU
1
;
Weidong JIA
;
Xiaofei QIAO
;
Fengping LIU
;
Lu CHEN
;
Chuanlai HU
Author Information
1. Department of Hepatic Surgery, Affiliated Provincial Hospital, Anhui Medical University, Hefei 230001, China
- Publication Type:Journal Article
- Keywords:
Liver neoplasms;
Hepatectomy;
Multimodal preventive analgesia
- From:
Chinese Journal of Surgery
2017;55(2):141-145
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinical values of multimodal preventive analgesia in patients with partial hepatectomy for liver cancer.
Methods:A perspective study was conducted to collect data of patients with liver cancer who underwent partial hepatectomy from March 2014 to March 2015.The 90 patients involved in the study were randomly divided into two groups as multimodal analgesia and control groups, and each group had 45 cases. In multimodal analgesia group, 40 mg parecoxib sodium was injected intravenously 30 minutes before anesthetic induction, and 0.375% ropivacaine 150 mg combined with dexamethasone 5 mg were applied to transversus abdominis plane block before closing abdomen.The patients in control group without above treatment. Patient controlled intravenous analgesia was used in all patients. Three days after surgery, 40 mg parecoxib sodium was injected intravenously, twice a day for all patients.Visual analogue scales (VAS) was used to evaluate postoperative pain, and postoperative adverse events were observed.The number of cases of postoperative ambulation (>6 h for every day), time of flatus and defecation, and duration of hospital stay were recorded in two groups.Pearson chi-square test was used to compare the rate or constituent ratio between two groups.Independent sample t test or Mann-Whitney U was used to analyzed the measurement data between two groups.
Results:There were no difference between two groups in aging, gender, weight, body mass index, ASA classification, blood loss volume, time of operation(all P>0.05). The scores of VAS in multimodal analgesia group was significantly lower than that in control group(3.0±0.8 vs. 4.6±1.1, t=7.814, P<0.01 for day 1; 2.2±1.0 vs. 3.6±1.2, t=5.825, P<0.01 for day 2; 1.6±0.8 vs. 2.4±1.2, t=3.894, P<0.01 for day 3). The number of cases of postoperative ambulation(>6 h) in multimodal analgesia group was significantly more than that in control group (10 cases vs. 0 case, χ2=11.250, P<0.01 for day 1; 21 cases vs. 5 cases, χ2=13.846, P<0.01 for day 2; 28 cases vs. 17 cases, χ2=5.378, P =0.020 for day 3). The time of flatus and defecation, and duration of hospital stay were significantly shorter than that in control group((30.2±7.3) hours vs. (36.4±7.0)hours, t=4.115, P<0.01 for flatus; (50.9±5.2)hours vs. (60.7±7.3)hours, t=7.346, P<0.01 for defecation; (6.2±0.8)days vs. (9.6±1.1)days, t=16.615, P<0.01 for hospital stay).
Conclusion:Multimodal preventive analgesia effectively alleviate the postoperative pain, benefits early ambulation, improves recovery of gastrointestinal function, and shortens duration of hospital stay in patients with partial hepatectomy for liver cancer.
